Updates
-
It’s finally official: Around 900,000 Americans and quite possibly more than that have multiple sclerosis (MS) — easily double the long-accepted figure of 400,000. ... Read more
-
Stuck in Delivery Limbo Land
Take a minute … and relax. It’s been a fraught few weeks of numerous solo hospital visits, as my wife was first dealing with ... Read more -
4 Things I’ve Learned About Paying for MS Medications
Are you having trouble paying for MS medications? If so, you’re not alone. People change or lose their insurance, and plans change the medications ... Read more -
Neurofilament Light Chain Levels in Blood of Value as Biomarker of MS Activity and Treatment Response, Study Finds
Blood levels of a nerve cell-derived component known as neurofilament light chain (NfL) could be used as a biomarker of disease severity and treatment ... Read more -
Tiny RNA miR-142 Key in Preventing Autoimmunity, Study Reports
A tiny molecule known as microRNA-142 plays a key role in the prevention of autoimmune responses through immune cells called regulatory T-cells (Tregs), according ... Read more
-
Need to Know: Do Children Get Multiple Sclerosis?
Editor’s note: “Need to Know” is a series inspired by common forum questions and ... -
There Are Angels Among Us: I’m Grateful for the Helpers
I like to keep my life as normal as possible. This can be difficult ... -
Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says
Multiple sclerosis patients who began treatment with Gilenya and stayed with it continuously showed a ... -
FDA Asked to Place Cannabis-based Therapy for Progressive MS on Fast Track, MMJ Holdings Says
A request for a potential cannabis-based treatment for multiple sclerosis to be given Fast Track designation, speeding its development ... -
Early-life Antibiotic Use Disrupts Gut Microbiota and Immune System, MS Rat Study Finds
Early-life use of antibiotics disrupts gut microbiota in a rat model of multiple sclerosis (MS) ... -
Almost 1 in 5 People Wrongly Diagnosed with MS at Two Specialized Centers in US, Study Finds
Almost one in five patients diagnosed with multiple sclerosis (MS) and referred to one ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more